Cyclerion Therapeutics (CYCN) Interest & Investment Income (2019 - 2020)

Cyclerion Therapeutics (CYCN) recorded quarterly Interest & Investment Income of -$4000.0 in Q4 2020, down 104.3% quarter-over-quarter from $93000.0 in Q3 2020, and down 100.75% on a YoY basis from $531000.0 in Q1 2020.

Cyclerion Therapeutics (CYCN) Interest & Investment Income (2019 - 2020) Analysis & Trends

Cyclerion Therapeutics' Interest & Investment Income history runs 2 years deep, the most recent figure standing at -$4000.0 for Q4 2020.

  • In Q4 2020, Interest & Investment Income fell 100.75% year-over-year to -$4000.0; the TTM figure through Dec 2020 stood at $588000.0 (changed N/A YoY), while the FY2020 annual figure was $588000.0, down 71.02% from the prior year.
  • Interest & Investment Income was -$4000.0 for Q4 2020 at Cyclerion Therapeutics, down from $93000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $800000.0 in Q2 2019 to a low of -$4000.0 in Q4 2020.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 597,319.59
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 40.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 305,000.00
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 103,341.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 114.80 Mn
9 Abivax 91.71 Bn 91.71 Bn - -14.79 Mn
10 Cyclerion Therapeutics 11.94 Mn 8.70 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 -4,000.00
Sep 30, 2020 93,000.00
Jun 30, 2020 138,000.00
Mar 31, 2020 361,000.00
Dec 31, 2019 531,000.00
Sep 30, 2019 699,000.00
Jun 30, 2019 800,000.00